Self-Host
Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Encompass Health Corp (EHC) Insider Trading Activity
Healthcare • Medical Care Facilities • 27,253 employees
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.
Total Value
-$4,208,032.35
Total Shares
-55,762
Average Trade Value
-$135,742.98
Most Active Insider
Tarr Mark J
Total Activity: $2,919,091
Largest Single Transaction
$2,919,091
by Tarr Mark J on Jan 1, 2025
30-Day Activity
11 Transactions
Volume: 980 shares
Value: $905,447
|
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
|---|---|---|---|---|---|---|
|
Director
|
Jan 16, 2025 | 292 | $27,565 | 4,709 (+6.2%) | Grant | |
|
Director
|
Jan 16, 2025 | 375 | $35,393 | 12,632 (+3.0%) | Grant | |
|
Director
|
Jan 15, 2025 | 83 | $93,610 | 46,105 (+0.2%) | Grant | |
|
Director
|
Jan 15, 2025 | 25 | $93,610 | 13,293 (+0.2%) | Grant | |
|
Director
|
Jan 15, 2025 | 25 | $93,610 | 13,647 (+0.2%) | Grant | |
|
Director
|
Jan 15, 2025 | 36 | $93,610 | 19,695 (+0.2%) | Grant | |
|
Director
|
Jan 15, 2025 | 16 | $93,610 | 12,257 (+0.1%) | Grant | |
|
Director
|
Jan 15, 2025 | 14 | $93,610 | 8,429 (+0.2%) | Grant | |
|
Director
|
Jan 15, 2025 | 25 | $93,610 | 17,137 (+0.1%) | Grant | |
|
Director
|
Jan 15, 2025 | 6 | $93,610 | 4,417 (+0.1%) | Grant | |
|
Director
|
Jan 15, 2025 | 83 | $93,610 | 46,105 (+0.2%) | Grant | |
|
Chief Accounting Officer
Officer
|
Jan 1, 2025 | 2,446 | $225,888 | 74,206 (-3.3%) | Payment of Exercise Price | |
|
Evp, Gen Counsel Secretary
Officer
|
Jan 1, 2025 | 5,917 | $546,435 | 78,856 (-7.5%) | Payment of Exercise Price | |
|
EVP Chief Financial Officer
Officer
|
Jan 1, 2025 | 12,438 | $1,148,649 | 58,560 (-21.2%) | Payment of Exercise Price | |
|
Chief Medical Officer
Officer
|
Jan 1, 2025 | 2,991 | $276,219 | 15,603 (-19.2%) | Payment of Exercise Price | |
|
Sr. Vice Pres. and Treasurer
Officer
|
Jan 1, 2025 | 2,291 | $211,574 | 99,786 (-2.3%) | Payment of Exercise Price | |
|
President CEO
Director, Officer
|
Jan 1, 2025 | 31,609 | $2,919,091 | 522,489 (-6.0%) | Payment of Exercise Price | |
|
Director
|
Oct 17, 2024 | 362 | $35,306 | 12,241 (+3.0%) | Grant | |
|
Director
|
Oct 17, 2024 | 283 | $27,629 | 4,411 (+6.4%) | Grant | |
|
Director
|
Oct 15, 2024 | 14 | $96,330 | 8,415 (+0.2%) | Grant | |
|
Director
|
Oct 15, 2024 | 35 | $0 | 19,659 (+0.2%) | Grant | |
|
Director
|
Oct 15, 2024 | 6 | $96,330 | 4,128 (+0.1%) | Grant | |
|
Director
|
Oct 15, 2024 | 24 | $96,330 | 17,112 (+0.1%) | Grant | |
|
Director
|
Oct 15, 2024 | 24 | $96,330 | 13,268 (+0.2%) | Grant | |
|
Director
|
Oct 15, 2024 | 81 | $96,330 | 46,022 (+0.2%) | Grant | |
|
Director
|
Oct 15, 2024 | 24 | $96,330 | 13,622 (+0.2%) | Grant | |
|
Director
|
Oct 15, 2024 | 81 | $96,330 | 46,022 (+0.2%) | Grant | |
|
Director
|
Oct 15, 2024 | 16 | $96,330 | 11,879 (+0.1%) | Grant | |
|
EVP Chief Financial Officer
Officer
|
Aug 13, 2024 | 12,162 | $1,049,945 | 136,325 (-8.9%) | Sale | |
|
EVP Chief Financial Officer
Officer
|
Aug 13, 2024 | 12,260 | $439,276 | 148,487 (+8.3%) | Exercise/Conversion | |
|
EVP Chief Financial Officer
Officer
|
Aug 13, 2024 | 98 | $8,529 | 136,227 (-0.1%) | Sale |